A Message from John Flatley

Cystic Fibrosis is a disease that affects many children, adults, and families. I fervently believe that a cure can be found from our work at the Flatley Discovery Lab. We are working for this cure and we are also praying for it. I feel the two go hand-in-hand. For every child afflicted with this disease we pray for a miracle. But we also pray that there will be a miraculous discovery for that needle in the haystack in a field of haystacks. So we are trying to provide the means and the mechanism to discover that tiny, elusive molecule.

News & Developments

Oct 10, 2013 Flatley Discovery Lab, LLC Nominates Clinical Candidate for Treatment of Cystic Fibrosis
CHARLESTOWN, Mass.--(PRESS ENTITY)—October 10, 2013—Flatley Discovery Lab, LLC today announced that it has nominated FDL169, an orally available small molecule for the treatment of Cystic Fibrosis, as a clinical candidate and initiated IND-enabling st
Dec 3, 2012 Hub lab seeks wider cystic fibrosis cure
Word last week that the U.S. Food and Drug Administration had approved a drug developed by a Cambridge biotech company to treat a rare form of cystic fibrosis that affects about 1,200 people upped the ante for a lab in neighboring Charlestown...
Dec 3, 2012 Venture firm backs start-ups targeting cystic fibrosis
John Flatley, a real estate developer and philanthropist, has founded an investment group called Flatley Venture Capital to back life sciences start-ups with potential treatments for the genetic disease cystic fibrosis. Flatley, who has a close relative w
Dec 3, 2012 WHOI teaming with Flatley Discovery Lab in search for effective treatments for cystic fibrosis.
The Woods Hole Oceanographic Institution (WHOI) has signed a $1.18 million agreement with the Flatley Discovery Lab in Charlestown, Mass., to investigate and supply marine microbial extracts as possible treatments for cystic fibrosis (CF).